Depemokimab is a monoclonal antibody targeting ... GSK's vaccine Arexvy must include warnings about a rare neurological side effect, Guillain-Barré syndrome. Meanwhile, the company's ...

Depemokimab is a monoclonal antibody targeting interleukin ... The FDA has directed that GSK's vaccine Arexvy must include warnings about a rare neurological side effect, Guillain-Barré syndrome.

Blenrep and depemokimab are expected to launch in ... Luke Miels highlighted that improved understanding of dosing and managing side effects positions Blenrep for a successful relaunch, with ...

Depemokimab, our new long-acting anti-IL ... Blenrep and have a better understanding of how to mitigate eye-related side effects. Around a third of patients in Blenrep studies have reported ...